Effect of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model: Implications for brain tumor therapy

Neurosurgery

Volumn 41, Issue 6, 1997, Pages 1374-1384

  Bampoe, Joseph ^a   Glen, Jennifer ^a   Mackenzie, Ian ^a,b   Porter, Phil ^a   Bernstein, Mark ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Brachytherapy; Rat brain tumor model; Surgery; Survival times

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA; MALE; MICROSURGERY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT;

EID: 0030781204     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199712000-00026     Document Type: Article

References (51)

1. Agbi CB, Bernstein M, Laperriere N, Leung P, Lumley M: Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiat Oncol Biol Phys 23:321-326, 1992.
2. Ammirati M, Vick N, Liao Y, Ciric I, Mikhael M: Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21:201-206, 1987.
3. Anonymous: Prognostic factors for high-grade glioma: Development of a prognostic index - A report of the Medical Research Council Brain Tumour Working Party. J Neurooncol 9:281-283, 1990.
4. Barker M, Deen DF, Baker DG: BCNU and x-ray therapy of intracerebral 9L rat tumors. Int J Radiat Oncol Biol Phys 5:1581-1583, 1979.
5. Barker M, Hoshino T, Gurcay O, Wilson CB, Neilson SL, Downie R, Eliason J: Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 33:976-986, 1973.
6. Bashir R, Hochberg F, Oot R: Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 23:27-30, 1988.
7. Bernstein M, Ginsberg H: Protection of iodine-125 brachytherapy brain injury in the rat with the 21-aminosteroid U-74389F. Neurosurgery 31:923-928, 1992.
8. Bernstein M, Laperriere N, Leung P, McKenzie S: Interstitial brachytherapy for malignant brain tumors: Preliminary results. Neurosurgery 26:371-380, 1990.
9. 125I brachytherapy evaluated by MR imaging, a blood-brain barrier tracer, and light and electron microscopy in a rat model. J Neurosurg 73:585-593, 1990.
10. Chapman JD, Allalunis-Turner MJ: Cellular and molecular targets in normal tissue radiation injury, in Gutin PH, Leibel SA, Sheline GE (eds): Radiation Injury to the Nervous System. New York, Raven Press, 1991, pp 3-15.
11. 125I brachytherapy: A study of seven autopsy cases. Acta Neurochir (Wien) 33:301-306, 1984.
12. de Tribolet N, Sawamura Y: Can brain tumors be cured? Results of clinical trials, in Crockard A, Hayward R, Hoff JT (eds): Neurosurgery: The Scientific Basis of Clinical Practice. Boston, Blackwell Scientific Publishers, 1992, ed 2, pp 585-598.
13. 125I sources: A canine model evaluated by quantitative computed tomography. Neurosurgery 16:530-537, 1985.
14. Green SB, Shapiro WR, Burger PC, Selker RG, VanGilder JC, Saris S, Malkin MG, Mealey J, Neal J, Robertson JT, Olson J: A randomized trial of interstitial radiotherapy (RT) boost for newly diagnosed malignant glioma, in Brain Tumor Cooperative Group (BTCG) Trial 8701. Dallas, American Society of Clinical Oncology, 1994, p 174 (abstr).
15. 125I interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg 67:895-902, 1987.
16. Gutin PH, Bernstein M, Sano Y, Deen DF: Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the rat brain tumor and spheroid models: Implications for brain tumor brachytherapy. Neurosurgery 15:781-786, 1984.
17. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, Silver P, Da Silva V, Edwards MS, Davis RL, Weaver KA, Lamb S: Recurrent malignant gliomas: Survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67:864-873, 1987.
18. Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P, Lamborn K, Lamb S, Ham B: External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21:601-606, 1991.
19. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911, 1980.
20. Hoshino T: Therapeutic implications of brain tumor cell kinetics. Natl Cancer Inst Monogr 46:29-35, 1977.
21. Hoshino T, Wilson CB: Review of basic concepts of cell kinetics as applied to brain tumors. J Neurosurg 42:123-131, 1975.
22. Kaye AH, Gonzales MF: Biology of brain tumors, in Hayward R, Hoff JT (eds): Neurosurgery: The Scientific Basis of Clinical Practice. Boston, Blackwell Scientific Publishers, 1992, ed 2, pp 527-543.
23. Kaye AH, Laidlaw JD: Chemotherapy of gliomas. Curr Opin Neurol Neurosurg 5:526-533, 1992.
24. Kelly PJ, Daumas-Duport C, Kispert DB, Kail BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987.
25. Kim JH, Alfieri AA, Rosenblum M, Bravo S, Kim SH: Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain. J Neurooncol 9:9-15, 1990.
26. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993.
27. Leibel SA, Gutin PH, Davis RL: Factors affecting radiation injury after interstitial brachytherapy for brain tumors, in Gutin PH, Leibel SH, Sheline GE (eds): Radiation Injury to the Nervous System. New York, Raven Press, 1991, pp 257-270.
28. Leibel SA, Scott CB, Loeffler JS: Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 21:198-219, 1994.
29. Levin VA: Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684, 1980.
30. Levin VA, Kabra P: Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors. Cancer Chemother Rep 58:787-792, 1974.
31. Levin VA, Stearns J, Byrd A, Finn A, Weinkam RJ: The effect of phenobarbital pretreatment on the antitumor activity of BCNU, CCNU, and PCNU and on the pharmacokinetics and biotransformation of BCNU. J Pharmacol Exp Ther 208:1-6, 1979.
32. Loeffler JS, Alexander E III, Hochberg FH, Wen PY, Morris JH, Schoene WC, Siddon RL, Morse RH, Black PM: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19:1455-1462, 1990.
33. Loeffler JS, Alexander E, Wen PY, Shea WM, Coleman CN, Kooy HM, Fine HA, Nedzi LA, Silver B, Riese NE, Black PMcL: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82:1918-1921, 1990.
34. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331-344, 1990.
35. Rockwell S: In vivo-in vitro systems: New models for studying the response of tumours to therapy. Lab Anim Sci 27:831-851, 1977.
36. Rockwell S: In vivo-in vitro tumour cell lines: Characteristics and limitations as models for human cancer. Br J Cancer Suppl 41:118-122, 1980.
37. Rosenblum MK, Knebel KD, Vasquez DA, Wilson CB: Brain-tumor therapy: Quantitative analysis using a model system. J Neurosurg 46:145-154, 1977.
38. Rosenblum ML, Wheeler KT, Wilson CB, Barker M, Knebel KD: In vitro evaluation of an in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 35:1387-1391, 1975.
39. Salazar OM, Rubin P: The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1:627-637, 1976.
40. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Acord P, Lamborn KR, Lamb SA, Ham B, Gutin PH: High activity iodine-125 interstitial implants for gliomas. Int J Radiat Oncol Biol Phys 24:583-591, 1992.
41. Shapiro W: Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13:38-45, 1986.
42. Shrieve DC, Loeffler JS: Advances in radiation therapy for brain tumors. Neurol Clin 13:773-793, 1995.
43. Sneed PK, Gutin PH, Larson DA, Malek MK, Phillips TL, Prados M, Scharfen CO, Weaver KA, Wara WM: Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29:719-727, 1994.
44. Tel E, Hoshino T, Barker M, Wilson CB: Effect of surgery on BCNU chemotherapy in a rat brain tumor model. J Neurosurg 52:529-532, 1980.
45. Deleted in proof.
46. Turowski K, Fike JR, Cann CE, Higgins RJ, Davis RL, Gutin PH, Phillips TL, Weaver KA: Normal brain iodine-125 radiation damage: Effect of dose and irradiated volume in a canine model. Radiology 158:833-838, 1986.
47. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin M: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989.
48. Weizsaecker M, Deen DF, Rosenblum ML, Hoshino T, Gutin PH, Barker M: The 9L rat brain tumor: Description and application of an animal model. J Neurol 224:183-192, 1981.
49. Wheeler KT, Levin VA, Deen DF: The concept of drug dose for in vitro studies with chemotherapeutic agents. Radiat Res 76:441-158, 1978.
50. Whittle IR, Gregor A: The treatment of primary malignant brain tumours. J Neurol Neurosurg Psychiatry 54:101-103, 1991.
51. Willis BK, Heilbrun MP, Sapozink MD, McDonald PR: Stereotactic interstitial brachvtherapy of malignant astrocytomas with remarks on postimplantation computed tomographic appearance. Neurosurgery 23:348-354, 1988.